INTRODUCTION
Macrophages are a key cell type involved in the systemic response to bacterial products, such as endotoxin (lipopolysaccharide, LPS). These bacterial products activate macrophages via their Toll-like receptors to produce large amounts of inflammatory mediators. 1 These mediators cause tissue damage and they are largely responsible for the lethal effects of bacterial endotoxin. We have recently demonstrated that exposure of macrophages to classical activating signals in the presence of IgG immune complexes induces the development of a cell type that is fundamentally different from the classically activated macrophage. 2 In contrast to the inflammatory-activated macrophages, cells exposed to IgG immune complexes generated large amounts of IL-10 and, as a result, are potent inhibitors of acute inflammatory responses to bacterial endotoxin. 3 These macrophages have been called type II activated macrophages 2 because in addition to reversing inflammation, they also preferentially induce T-helper 2 (Th2) type responses to antigen.
We have begun to characterize these type II activated macrophages and determine the conditions under which these cells reverse inflammatory diseases or enhance antibody production. Here we show that macrophages exposed to immune complexes can prevent lethal endotoxemia and they can also influence the amount and isotype of IgG that is produced in response to antigen.
MATERIALS AND METHODS

In vitro assays
Cytokine production from bone marrow-derived macrophages was measured by ELISA, using the following antibody pairs: IL-12 p40, C15.6 + C17.8; IL-12 p70, 9A5 + C17.8; IL-10, JES5-2A5 + JES5-16E. Recombinant standards were purchased from BD PharMingen (San Diego, CA, USA). Cytokine mRNA levels were measured by RT-PCR and by RNAse protection. RNA was reverse transcribed and amplified as previously described. 4 For RNAse protection assays, RNA was prepared and assayed using the multiprobe template sets mCK-2b and mCK-3b (BD PharMingen) according to the manufacturer's instructions.
T-cell stimulation assays were performed as described previously. 5 Briefly, CD4 + cells were prepared from the spleens of DO11.10 mice by immunomagnetic negative depletion (Polysciences, Inc., Warrington, PA USA). For primary stimulation assays, 2 × 10 5 macrophages were primed overnight with 100 U/ml of rIFN-(R&D Systems, Minneapolis, MN, USA). Cells were washed and stimulated with 10 ng/ml LPS (Escherichia coli O127:B8; Sigma, St Louis, MO, USA) in the presence of 150 mg/ml ovalbumin (OVA; Sigma) or IgG-opsonized ovalbumin (IgG-OVA). Following macrophage activation, 5 × 10 5 CD4 + T cells were added to each well in a total volume of 0.6 ml of RPMI 1640 (Cellgro, Hearndon, VA, USA) supplemented with 10% FCS, HEPES, sodium pyruvate, penicillin/streptomycin, and 2-mercaptoethanol. Seven days following the primary stimulation, CD4 + cells were harvested, washed and counted, and added to 3 × 10 5 fresh macrophages with 150 mg/ml ovalbumin (secondary stimulation, unbiasing conditions). After 24 h, cytokines were measured by ELISA.
In vivo assays
For in vivo cytokine production, RAG-1 -/mice were injected with anti-LPS IgG antibody or saline in the peritoneum followed 2 h or 18 h later by 4 mg of LPS (E. coli O128:B12) intravenously in the tail vein. Mice were bled by retro-orbital puncture at 2-8 h post-injection, and serum cytokine levels were determined by ELISA as described. 3 For in vivo reconstitution assays, 1 × 10 6 BM macrophages were incubated with 1 × 10 7 E-IgG immune complexes in the presence of 5 ng/ml LPS (E. coli O127:B8) at 37°C in 1.5-ml Eppendorf tubes for 30 min and then injected intraperitoneally into C57BL/6 mice. After 3 h, mice were injected intraperitoneally with 300 mg of LPS (E. coli K235). Animals were then monitored at 12-h intervals for 5 days, and viability was recorded. For macrophage transfer studies, macrophages were primed in vitro for 6 h with IFN-and stimulated with 10 ng/ml LPS in the presence or absence of E-IgG immune complexes. A total of 2 × 10 6 macrophages were injected i.p. into mice prior to immunization with 50 mg OVA in the absence of adjuvant. This procedure was repeated at 10 days. Serum was collected from all mice on day 21 and an ELISA was performed for antibody measurements as described previously. 2 For OVAspecific immunoglobulin determinations, plates were incubated with alkaline phosphatase-conjugated goat anti-mouse Ig (H+L), IgG1, or IgG2a (Southern Biotechnology Associates, Birmingham, AL, USA). Antibody titers were determined as the final dilution of sera that yielded an OD value at 405 nm in excess of 0.1.
RESULTS
The basic observation
Macrophages were activated by conventional means, and their cytokine production was measured by a number of criteria at both the protein 3 and mRNA levels ( Fig.  1 ). As expected, activated macrophages produced a variety of inflammatory mediators, including relatively high levels of the cytokines, TNF, IL-1, IL-6, MIF, and IL-12. These activated macrophages also produced modest amounts of the potentially anti-inflammatory TGF-and IL-10 ( Fig. 1 ). Parallel wells of cells were activated in the same way, but at the time of activation they were also exposed to E-IgG immune complexes. These cells made essentially the same cytokine profile with two dramatic exceptions. The presence of immune complexes at the time of activation prevented the production of IL-12 (p40 and p35) and it induced the production of high levels of IL-10 ( Fig. 1 ). We have begun to study the biological significance of the specific alteration in the production of these two cytokines, IL-10 and IL-12, by these type II activated macrophages.
Type II activated macrophages and endotoxemia
The dramatic induction of IL-10 by these macrophages suggested that they would have anti-inflammatory properties. To test this, a murine model of in vivo LPS responsive-ness was implemented. 3 First, mice were injected with either LPS alone or LPS opsonized with an IgG antibody (IgG-LPS). As expected, the injection of LPS induced high amounts of IL-12 p40 and modest levels of IL-10 ( Table 1) . Injection of IgG-LPS, however, resulted in the production of reduced amounts of IL-12 and increased amounts of IL-10 (Table 1) . These initial studies were done in RAG -/mice, which lack naturally occurring antibodies to LPS. To test the extent to which type II activated macrophages could prevent lethal endotoxemia, type II activatedmacrophages were generated in vitro and transferred into C57BL/6 mice, which then received 300 mg LPS/mouse i.p. Mice that received 1 × 10 6 type II macrophages remained completely viable and healthy throughout the observation period (Fig. 2) , whereas mice that received control macrophages succumbed to lethal endotoxemia within 48 h. 3 To show that this effect was due to IL-10 secretion, type II activated macrophages from IL-10 -/mice were used in parallel. These macrophages failed to rescue mice from lethal endotoxemia (Fig. 2) . Thus, by virtue of their secretion of IL-10, type II activated macrophages exert a potent anti-inflammatory effect that can be exploited to prevent acute pathologies, such as those associated with LPS endotoxemia.
The name type II activated macrophages was derived from their ability to preferentially induce Th2-type adaptive immune responses. In vitro studies were performed using either classically or type II activated macrophages as antigen-presenting cells. Classically activated macro- phages stimulated T cells to produce primarily IFN-in response to antigen, whereas type II activated macrophages induced naïve CD4 + T cells to produce high levels of IL-4. 5 This bias in T-cell cytokine production by these two populations of antigen-presenting cells (APCs) was stable and preserved when T cells were subsequently restimulated under a variety of non-biasing conditions. T-cell cytokine production correlated with APC cytokine production ( Fig. 3) . IL-12 secretion by classically activated macrophages induced IFN-production by T cells, whereas IL-10 secretion by type II activated macrophages resulted in IL-4 production by T cells. 5 Macrophages from knockout mice lacking IL-12 failed to induce Th1 responses, and macrophages deficient in IL-10 failed to induce Th2 responses (Fig. 3) . Thus, the reciprocal production of IL-10 and IL-12 by activated macrophages as APCs influences the character of T-cell responses to antigen.
Modulating macrophage function with IgG immune complexes 479
Days post LPS challenge
To determine the extent to which type II activated macrophages could influence antibody responses to antigen, mice were injected with either type II or classically activated macrophages along with OVA antigen in the absence of any other adjuvant. 2 Mice vaccinated with OVA in the presence of type II activated macrophages had higher titers of IgG antibody to OVA (titer = 6800) relative to mice receiving classically activated macrophages (titer = 2900), and they made significantly more OVA-specific IgG1 isotype (titer = 8100 versus 2600). This observation suggested that the presence of type II activated macrophages alone was sufficient to induce (Th2-like) IgG class switching. Thus the ligation of Fc R on activated macrophages by antigen-IgG complexes induced T cells to produce IL-4, which in turn induced B cells to produce IgG1 in response to that antigen.
DISCUSSION
We recently demonstrated that IgG immune complexes have a dramatic and unexpected effect on the phenotype of activated macrophages. Macrophages that are activated in the presence of immune complexes produce high levels of IL-10 and, as a result, exert a potent antiinflammatory effect on the immune response. These cells can prevent lethal endotoxemia and they can preferentially induce T cells to produce IL-4 and initiate a Th2-type immune response. 3, 5 We have termed these cells type II activated macrophages. Fig. 3 . CD4 + T cell activation by macrophages from gene knockout mice. Activated macrophages from wild-type, IL-12 -/-, or IL-10 -/mice were given either OVA or IgG-OVA followed by the addition of CD4 + T cells. Macrophage cytokine production was measured 24 h later (left side). One week following stimulation, T cells were harvested, washed, and re-stimulated with wild-type unactivated macrophages. T-cell cytokine production was measured 24 h later. Data are the mean ± SD of a representative experiment of three. This figure originally appeared in Anderson and Mosser 5 and is reproduced with the permission of The American Association of Immunologists, Inc. from The Journal of Immunology.
T-cell cytokines
The anti-inflammatory effects of these type II activated macrophages were demonstrated in a murine model of endotoxemia. Previous in vitro studies 4, 6 demonstrated that LPS induced different macrophage cytokine responses than IgG-LPS. LPS induced high levels of IL-12 but only modest levels of IL-10, whereas IgG-LPS induced the reciprocal pattern of cytokine production. By several criteria, at both the mRNA and protein levels, only these two cytokines were affected by the addition of immune complexes. To test the biological relevance of this reciprocal cytokine production in vivo, mice were administered LPS or IgG-LPS in vivo. Consistent with our in vitro studies, mice receiving LPS made more IL-12 and less IL-10 than mice receiving IgG-LPS. To determine the extent to which these cells could prevent lethal endotoxemia, only 1 × 10 6 type II activated macrophages were transferred into mice, which were injected with high doses of LPS. Type II activated macrophages from wild-type, but not IL-10 -/mice, prevented lethal endotoxemia. 3 In this model, the injection of type II activated macrophages before the infusion of LPS prevented lethal TNF production.
To examine the extent to which these macrophages could influence an adaptive immune response, these cells were used as APCs to stimulate T-cell cytokine production in vitro. We also showed that the ligation of Fc R on activated macrophages could preferentially drive Th2-like responses. Thus, in some settings, IgG itself may be an important inducer of Th2-like responses. The mechanism by which IgG can influence immune deviation is by changing the phenotype of the APC, inducing the production of IL-10 instead of IL-12. This is in stark contrast to classically activated macrophages, which induced a Th1 response characterized by T cells producing high levels of IFN-.
CONCLUSIONS
The phenotype of activated macrophages can be dramatically changed by ligating their Fc receptors. Activated macrophages have been shown to be important APCs in a variety of autoimmune and inflammatory diseases where the Th1-inducing cytokine production of these cells may contribute to pathology. 7-10 Thus, these observations may have both conceptual and applied implications. The reciprocal reversal of cytokine production that we describe may be exploited to modulate pathologies associated with autoimmune diseases associated with Th1-like responses. Conversely, the induction of Th2-like responses following Fc R ligation may be exploited to improve IgG responses to weakly immunogenic antigens.
